Sign in

CIK 0001018735 · Accelerated filer

NYMOX PHARMACEUTICAL CORP

Sign in to watch
Ticker
NYMXF
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Entity type
other
Phone
1-800-936-9669
Business address
9900 CAVENDISH BLVD., SUITE 306, ST. LAURENT, QUEBEC CANADA, Quebec, Canada, H4M 2V2
  1. 6-K Event Report of Foreign Issuer
  2. SC 13G Stake Amended Statement of Ownership
  3. 6-K Event Report of Foreign Issuer
  4. POS AM Other Post-effective Amendment for Registration Statement
  5. 20-F/A Report Annual and Transition Report of Foreign Private Issuers
  6. 20-F Report Annual and Transition Report of Foreign Private Issuers
  7. 6-K Event Report of Foreign Issuer
  8. 6-K Event Report of Foreign Issuer
  9. F-3 Offering F-3
  10. POS AM Other Post-effective Amendment for Registration Statement
  11. 6-K Event Report of Foreign Issuer
  12. POS AM Other Post-effective Amendment for Registration Statement
  13. 6-K Event Report of Foreign Issuer
  14. 424B3 Offering Prospectus
  15. POS AM Other Post-effective Amendment for Registration Statement
  16. 6-K Event Report of Foreign Issuer
  17. POS AM Other Post-effective Amendment for Registration Statement
  18. 20-F Report Annual and Transition Report of Foreign Private Issuers
  19. 424B3 Offering Prospectus
  20. 6-K Event Report of Foreign Issuer

Page 19 of 21 · 408 filings